WHO WE ARE
Asia is colorful
and full of opportunity. However, navigating these diverse markets can also be complicated, resource intensive and frustrating without strong local knowledge and infrastructure.
Everlife invests strategically in distribution companies in the region with the aim to provide customers with more complete and advanced medical and laboratory solutions in areas where it matters.
Supplying physicians, researchers and industry professionals with the world’s most trusted brands
Everstone invests in Chemopharm, a leading Southeast Asian distributor
Singapore, November 23, 2017 – The Everstone Group via its platform Everlife has acquired Malaysia-based Chemopharm Sdn Bhd...
Everstone-backed Everlife invests in Chennai based CPC Diagnostics
Mumbai, March 13, 2019 – The Everstone Group via its healthcare platform Everlife has acquired a stake in Chennai based CPC Diagnostics...
CPC Diagnostics and YHLO jointly launch iFlash CLIA System in India
April 2019 - CPC Diagnostics, a leading IVD manufacturer and distributor in India, and YHLO, a leading company for immunoassays...
Chemopharm announces expanded distribution partnership with Mindray
April, 2019 – Chemopharm Sdn Bhd, an Everlife investment and leading laboratory and medical devices distributor...
Everlife joins the Asia Pacific Medical Technology Association (APACMed)!
May 2019 – Founded in 2014, the Asia Pacific Medical Technology Association (APACMed)